Jasper Ridge Partners, L.P. Mersana Therapeutics, Inc. Transaction History
Jasper Ridge Partners, L.P.
- $3.98 Billion
- Q2 2025
A detailed history of Jasper Ridge Partners, L.P. transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Jasper Ridge Partners, L.P. holds 23,100 shares of MRSN stock, worth $234,003. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,100
Previous 23,100
-0.0%
Holding current value
$234,003
Previous $7,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MRSN
# of Institutions
84Shares Held
94.1MCall Options Held
34.3KPut Options Held
14K-
Nextech Invest Ag12.1MShares$122 Million3.22% of portfolio
-
Nextech Invest, Ltd. Zurich, V812.1MShares$122 Million0.68% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$87.8 Million0.78% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$84.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.68MShares$77.8 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $984M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...